HOME >> MEDICINE >> NEWS
Notch signaling molecule important in type 2 immunity

(Philadelphia, PA) - Defects in immune system cells called T helper cells may lead to diseases characterized by a faulty inflammatory response such as autoimmunity and asthma. Understanding the molecular steps involved in how T helper cells mature may help researchers develop treatments for these diseases.

Helper T cells differentiate into two different types of cells Th1 or Th2 which are responsible for regulating immunity to different types of pathogens. Now, researchers at the University of Pennsylvania School of Medicine have shed light on a key molecular switch in this differentiation.

Notch is a protein that is a critical regulator of the process by which stem and other multipotent cells take on a specialized function, such as a T lymphocyte or a nerve cell in organisms ranging from fruitflies to humans. Using mice in which Notch signaling could be induced to turn off in mature T cells, the researchers showed that Notch signaling is an important determinant of whether an organism can mount an effective Th2 response. The mice lacking Notch signaling were unable to mount a protective Th2 cell response against infection by the gastrointestinal parasitic worm Trichuris muris. However, the mice did mount a healthy Th1 response to an infection by the intracellular parasite Leishmania major, showing that Notch signaling is specifically required for the Th2 arm of the immune system.

These findings indicate that regulating Notch signaling may have a therapeutic role in treating diseases caused by abnormally increased Th2 responses, such as asthma, autoimmunity, and some forms of inflammatory bowel disease. Drugs that inhibit Notch signaling, called gamma secretase inhibitors, are currently in clinical trials for T-cell leukemia and Alzheimer's disease. This study published in today's issue of the Journal of Experimental Medicine suggests that these drugs may be useful in treating diseases typified by increased Th2 responses.

Senior au
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
17-Oct-2005


Page: 1 2 3

Related medicine news :

1. Notch protein signaling directs early T-cell development
2. Flick of whiskers helps tease out brains shadow signaling system
3. Macrophage signaling may affect hormone resistance in prostate tumors
4. Scientists from the CIMA investigate a molecule for diagnosing hypertensive cardiopathy
5. Hybrid molecule causes cancer cells to self-destruct
6. Electric jolt triggers release of biomolecules, nanoparticles
7. Case and Cleveland Clinic researchers identify molecule in age-related macular degeneration
8. Researchers find molecule that may hold key to learning and memory
9. UCSF research pinpoints brain molecules role in developing addiction
10. Study identifies molecule essential for proper localization of blood stem cells
11. Research clarifies how brain replenishes memory-making molecules

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Notch signaling molecule important type immunity

(Date:2/27/2015)... 27, 2015 The report analyzes the ... the global celiac disease market. It also assesses key ... development activities, and investments. , Celiac disease is an ... the small intestine. Celiac disease often has a genetic ... people is affected by celiac disease across the globe. ...
(Date:2/27/2015)... WI (PRWEB) February 27, 2015 UAS ... Adult Cubes, at Natural Products Expo West, March 6 ... are very excited to release the hands down best ... cream taste with an extra zing of Vitamin C. ... Cubes, winner of the NutrAward 2014, Delicious Living’s Supplement ...
(Date:2/27/2015)... 27, 2015 The Willliams Companies Inc ... Lincoln County, Wyoming. The plant processes natural gas ... interstate natural gas pipeline transport. It also produces natural ... plant initially began operations in 1958, and in recent ... gas production in Wyoming. The plant currently has ...
(Date:2/27/2015)... The Connecticut Community for Addiction Recovery ... Alcohol and Drug Recovery Centers (ADRC), for its shared ... were honored with the 2014 Commissioner’s Recognition Award by ... Last year, ROES achieved the highest rate ... are recovering from alcoholism and other drug addiction. ...
(Date:2/27/2015)... 2015 First Choice Emergency Room ... today. The new facility is located 25551 E. Smoky Hill ... are pleased to be a part of the Aurora community ... care here,” said Dr. Dombro, Facility Medical Director of First ... To celebrate the opening, First Choice Emergency Room made a ...
Breaking Medicine News(10 mins):Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2Health News:First Choice Emergency Room Opens New Facility in Aurora, Colorado 2
(Date:2/26/2015)... , Feb. 26, 2015  Unetixs ... noninvasive peripheral vascular physiologic testing solutions, today ... SSI, FR0010526814), the highly innovative medical imaging ... Doppler to bring SuperSonic Imagine,s technology to ... Unetixs SSI Aixplorer Ultrasound System combines ...
(Date:2/26/2015)... WORTH, Texas , February 26, 2015 ... Boston Scientific, Inc. (U.S) are the leaders in the ... , and Turkish neuromodulation market and is expected to lead ... in 1949, Medtronic, Inc. is the top player in the ... of implants for specific applications. Interstim and Entera Neurostimulator are ...
(Date:2/26/2015)... 2015 ANSYS (NASDAQ: ANSS ) ... diesel engines and global power leader, Cummins Inc., has ... to the ANSYS ® portfolio. This enterprise license ... of the industry,s most challenging multiphysics problems – providing ... on the market. The multi-year agreement provides ...
Breaking Medicine Technology:Unetixs Vascular Announces Partnership with SuperSonic Imagine 2Unetixs Vascular Announces Partnership with SuperSonic Imagine 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4Cummins Standardizes On ANSYS Engineering Simulation Software 2Cummins Standardizes On ANSYS Engineering Simulation Software 3
Cached News: